Datagov Opendata Platform

The Health Insurance Administration has selected evidence-based medical indicators to be publicly available in order to enhance the quality of medical care for patients with myocardial infarction, as a reference for relevant diseases when seeking medical treatment or assessing health care quality; Public indicators are divided into three categories based on treatment period and quality aspects, including in-hospital process assessment, assessment of continuation of medication after discharge, and outcome assessment. This includes the ratio of acute myocardial infarction (AMI) patients undergoing LDL cholesterol testing during hospitalization, the medication administration ratio for AMI patients during hospitalization, and at three, six, and nine months after discharge, as well as the ratio of emergency room revisit within three days after discharge due to the same primary diagnosis or related condition, and the unplanned readmission ratio within fourteen days after discharge due to the same primary diagnosis or related condition.